Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration

Summary

This study will evaluate visual improvement in patients treated with Immune Globulin Intravenous (Human), 10% Caprylate/Chromatography Purified (IGIV-C) or placebo who have Age-Related Macular Degeneration (AMD) with occult Choroidal Neovascularization (CNV).

Timeline

Start

2004-01

Primary completion

2005-05

Completion

2005-05

Drugs

Indications